• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激性心肌病不完全恢复是心血管死亡的主要决定因素。

Incomplete Recovery From Takotsubo Syndrome Is a Major Determinant of Cardiovascular Mortality.

作者信息

Matsushita Kensuke, Lachmet-Thébaud Lucie, Marchandot Benjamin, Trimaille Antonin, Sato Chisato, Dagrenat Charlotte, Greciano Stephane, De Poli Fabien, Leddet Pierre, Peillex Marilou, Hess Sébastien, Carmona Adrien, Jimenez Charline, Heger Joe, Reydel Antje, Ohlmann Patrick, Jesel Laurence, Morel Olivier

机构信息

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire.

UMR INSERM 1260 Regenerative Nanomedicine, Université de Strasbourg.

出版信息

Circ J. 2021 Sep 24;85(10):1823-1831. doi: 10.1253/circj.CJ-20-1116. Epub 2021 Apr 6.

DOI:10.1253/circj.CJ-20-1116
PMID:33828028
Abstract

BACKGROUND

Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with Takotsubo syndrome (TTS), recent studies have demonstrated a long-lasting functional impairment in those patients. The present study sought to evaluate the predictors of incomplete recovery following TTS and its impact on cardiovascular mortality.

METHODS AND RESULTS

Patients with TTS between 2008 and 2018 were retrospectively enrolled at 3 different institutions. After exclusion of in-hospital deaths, 407 patients were split into 2 subgroups according to whether their LVEF was >50% (recovery group; n=341), or ≤50% (incomplete recovery group; n=66) at the chronic phase. Multivariate logistic regression analysis found that LVEF (odds ratio [OR]: 0.94; 95% confidence interval [CI]: 0.91-0.98; P<0.001) and C-reactive protein levels (OR: 1.11; 95% CI: 1.02-1.22; P=0.02) at discharge were independent predictors of incomplete recovery. At a median follow up of 52 days, a higher cardiovascular mortality was evident in the incomplete recovery group (16% vs. 0.6%; P<0.001).

CONCLUSIONS

This study demonstrated that incomplete recovery after TTS is characterized by residual systemic inflammation and an increased cardiac mortality at follow up. Altogether, the present study findings determined that patients with persistent inflammation are a high-risk subgroup, and should be targeted in future clinical trials with specific therapies to attenuate inflammation.

摘要

背景

虽然Takotsubo综合征(TTS)患者的左心室射血分数(LVEF)有明显快速且自发的恢复,但最近的研究表明这些患者存在长期的功能损害。本研究旨在评估TTS后恢复不完全的预测因素及其对心血管死亡率的影响。

方法与结果

对2008年至2018年间3家不同机构的TTS患者进行回顾性纳入。排除院内死亡患者后,407例患者根据慢性期LVEF是否>50%(恢复组;n = 341)或≤50%(恢复不完全组;n = 66)分为2个亚组。多因素逻辑回归分析发现,出院时的LVEF(比值比[OR]:0.94;95%置信区间[CI]:0.91 - 0.98;P < 0.001)和C反应蛋白水平(OR:1.11;95% CI:1.02 - 1.22;P = 0.02)是恢复不完全的独立预测因素。在中位随访52天时,恢复不完全组的心血管死亡率更高(16%对0.6%;P < 0.001)。

结论

本研究表明,TTS后恢复不完全的特征是残留全身炎症以及随访时心脏死亡率增加。总之,本研究结果确定持续炎症患者是高危亚组,在未来临床试验中应以特定疗法减轻炎症为目标。

相似文献

1
Incomplete Recovery From Takotsubo Syndrome Is a Major Determinant of Cardiovascular Mortality.应激性心肌病不完全恢复是心血管死亡的主要决定因素。
Circ J. 2021 Sep 24;85(10):1823-1831. doi: 10.1253/circj.CJ-20-1116. Epub 2021 Apr 6.
2
Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients.残留炎症对Takotsubo综合征患者心肌恢复和心血管结局的影响。
ESC Heart Fail. 2021 Feb;8(1):259-269. doi: 10.1002/ehf2.12945. Epub 2020 Nov 18.
3
Systemic Inflammatory Response Syndrome Is a Major Determinant of Cardiovascular Outcome in Takotsubo Syndrome.全身性炎症反应综合征是心尖球形综合征心血管结局的主要决定因素。
Circ J. 2020 Mar 25;84(4):592-600. doi: 10.1253/circj.CJ-19-1088. Epub 2020 Mar 7.
4
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.Takotsubo 综合征患者左心室射血分数严重降低的长期预后。
Eur J Heart Fail. 2019 Jun;21(6):781-789. doi: 10.1002/ejhf.1373. Epub 2019 Feb 4.
5
Echocardiographic correlates of major adverse cardiac events at 1 year in patients with apical ballooning takotsubo syndrome.心尖球囊样综合征患者 1 年时主要不良心脏事件的超声心动图相关性。
Echocardiography. 2023 Feb;40(2):86-95. doi: 10.1111/echo.15524. Epub 2023 Jan 11.
6
Comparison of clinical profiles between takotsubo syndrome and acute coronary syndrome: a systematic review and meta-analysis.比较心尖球囊综合征与急性冠脉综合征的临床特征:系统评价与荟萃分析。
Heart Fail Rev. 2020 Sep;25(5):847-860. doi: 10.1007/s10741-019-09846-6.
7
Peri-operative Takotsubo syndrome after non-cardiac surgery: a retrospective nested case-control study.非心脏手术后围手术期 Takotsubo 综合征:一项回顾性巢式病例对照研究。
ESC Heart Fail. 2022 Oct;9(5):3149-3159. doi: 10.1002/ehf2.14015. Epub 2022 Jun 27.
8
Impact and management of left ventricular function on the prognosis of Takotsubo syndrome.左心室功能对Takotsubo综合征预后的影响及管理
Eur J Clin Invest. 2017 Jul;47(7):477-485. doi: 10.1111/eci.12768. Epub 2017 Jun 20.
9
Short- and medium-term prognosis of Takotsubo syndrome in a Portuguese population.葡萄牙人群中应激性心肌病的短期和中期预后
Rev Port Cardiol (Engl Ed). 2019 May;38(5):349-357. doi: 10.1016/j.repc.2018.07.010. Epub 2019 Jun 17.
10
Patient characteristics in variable left ventricular recovery from Takotsubo syndrome.Takotsubo综合征左心室恢复情况各异时的患者特征
Cardiovasc Revasc Med. 2018 Apr;19(3 Pt A):247-250. doi: 10.1016/j.carrev.2017.10.002. Epub 2017 Oct 5.

引用本文的文献

1
Comparison of clinical features and outcomes of Chinese patients with Takotsubo syndrome and acute myocardial infarction-results from the first Chinese Takotsubo syndrome registry.中国应激性心肌病患者与急性心肌梗死患者的临床特征及预后比较——来自首个中国应激性心肌病注册研究的结果
Cardiovasc Diagn Ther. 2025 Jun 30;15(3):563-573. doi: 10.21037/cdt-2025-8. Epub 2025 Jun 25.
2
Validation of Takotsubo Syndrome Scoring System.Takotsubo综合征评分系统的验证
Diagnostics (Basel). 2025 May 23;15(11):1314. doi: 10.3390/diagnostics15111314.
3
Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score.
应激性心肌病的死亡风险分层:结合InterTAK预后评分评估C反应蛋白测量值
ESC Heart Fail. 2025 Apr;12(2):1427-1436. doi: 10.1002/ehf2.15161. Epub 2025 Jan 16.
4
Takotsubo Syndrome or Peripartum Cardiomyopathy? Depends on Who You Are Talking to.应激性心肌病还是围产期心肌病?这取决于你问的是谁。
Behav Sci (Basel). 2024 Sep 5;14(9):777. doi: 10.3390/bs14090777.
5
Time Course of Left Ventricular Strain Assessment via Cardiovascular Magnetic Resonance Myocardial Feature Tracking in Takotsubo Syndrome.通过心血管磁共振心肌特征追踪评估Takotsubo综合征左心室应变的时间进程。
J Clin Med. 2024 May 30;13(11):3238. doi: 10.3390/jcm13113238.
6
Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.心源性休克幸存者的最佳心力衰竭药物治疗与死亡率:来自 FRENSHOCK 注册研究的见解。
J Am Heart Assoc. 2024 Mar 5;13(5):e030975. doi: 10.1161/JAHA.123.030975. Epub 2024 Feb 23.
7
The Immunology of Takotsubo Syndrome.Takotsubo 综合征的免疫学。
Front Immunol. 2023 Oct 6;14:1254011. doi: 10.3389/fimmu.2023.1254011. eCollection 2023.
8
Inflammatory Forms of Cardiomyocyte Cell Death in the Rat Model of Isoprenaline-Induced Takotsubo Syndrome.异丙肾上腺素诱导的Takotsubo综合征大鼠模型中心肌细胞死亡的炎症形式
Biomedicines. 2023 Jul 21;11(7):2060. doi: 10.3390/biomedicines11072060.
9
Takotsubo Cardiomyopathy: Current Treatment.应激性心肌病:当前的治疗方法
J Clin Med. 2021 Aug 2;10(15):3440. doi: 10.3390/jcm10153440.